TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/27/24 17:20 | 11/26/24 | ALNY | Alnylam Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | Fitzgerald Kevin Joseph | MA | O | CSO,EVP, | S.m | -755 | 251.65 | 0 | -3 | -18 | 13 | D | |||||||||||||||
8/14/24 16:12 | 8/12/24 | ALNY | Alnylam Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | Fitzgerald Kevin Joseph | MA | O | CSO,EVP, | M.d | 1,846 | 89.09 | 0 | 21 | 13 | D | ||||||||||||||||
8/14/24 16:12 | 8/12/24 | ALNY | Alnylam Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | Fitzgerald Kevin Joseph | MA | O | CSO,EVP, | S.d | -5,969 | 270.99 | 0 | -22 | -62 | 13 | D | |||||||||||||||
6/26/24 16:26 | 6/25/24 | ALNY | Alnylam Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | Fitzgerald Kevin Joseph | MA | O | CSO,EVP, | S | -277 | 230.99 | 0 | -1 | -8 | 15 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |